Related references
Note: Only part of the references are listed.Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder
L. Fredrik Jarskog et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes
A. J. Scheen et al.
DIABETES & METABOLISM (2013)
Effects of Adjunctive Metformin on Metabolic Traits in Nondiabetic Clozapine-Treated Patients With Schizophrenia and the Effect of Metformin Discontinuation on Body Weight: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study
Chun-Hsin Chen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression
Nancy Ho et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression
Ladan Kashani et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Considering metformin in cardiometabolic protection in psychosis
J. Curtis et al.
ACTA PSYCHIATRICA SCANDINAVICA (2012)
Metformin for schizophrenia
D. Taylor
ACTA PSYCHIATRICA SCANDINAVICA (2012)
Metformin for Treatment of Antipsychotic-Induced Amenorrhea and Weight Gain in Women With First-Episode Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Study
Ren-Rong Wu et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study
Mark L. Wahlqvist et al.
BMC MEDICINE (2012)
Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
Jing Wang et al.
CELL STEM CELL (2012)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Efficacy of metformin for prevention of weight gain in psychiatric populations: a review
Hannah Newall et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
Patrick Imfeld et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats
Hiranya Pintana et al.
LIFE SCIENCES (2012)
Efficacy and Safety of Metformin for Treatment of Overweight and Obesity in Adolescents: An Updated Systematic Review and Meta-Analysis
Carmen Bouza et al.
OBESITY FACTS (2012)
Clinical effect of metformin in children and adolescents with type 2 diabetes mellitus: A systematic review and meta-analysis
Mohammed A. Al-Shareef et al.
JOURNAL OF FAMILY AND COMMUNITY MEDICINE (2012)
Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
Chih-Cheng Hsu et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
Yaomin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Metformin therapy and clinical uses
John H. B. Scarpello et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology
M. S. Beeri et al.
NEUROLOGY (2008)
Share Paper
